-- Sailun Group (SHA:601058) posted 2025 attributable net profit of 3.52 billion yuan, down 13% from 4.06 billion yuan the previous year.
Earnings per share declined to 1.08 yuan from 1.25 yuan, according to a Tuesday filing with the Shanghai bourse.
Revenue rose 16% year over year to 36.8 billion yuan from 31.8 billion yuan.
Shares of the tire manufacturer were up 8% in recent trade.
Tamboran Resources (TBN) has an average rating of buy and mean price target of $57.40 according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Shanghai Pharmaceuticals (SHA:601607, HKG:2607) recorded a 6.4% rise in attributable profit in the first quarter of 2026 to 1.42 billion yuan from 1.33 billion yuan a year prior, according to a Wednesday Hong Kong bourse filing.The pharma company's earnings per share rose to 0.3823 yuan from 0.3595 yuan in the corresponding period of the previous fiscal year.Revenue jumped 6.4% to 75.3 billion yuan from 70.8 billion yuan in the year-ago period.